Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gideon Fleminger

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Molecular Recognition : JMR|June 24, 2021
The moonlighting activities of dihydrolipoamide dehydrogenase: Biotechnological and biomedical applicationsGideon Fleminger, Avraham Dayan
Journal of Molecular Recognition : JMR|February 6, 2009
Affinity 2007Gideon Fleminger, George Ehrlich
Molecules (Basel, Switzerland)|April 14, 2026
Titanium Dioxide in Biomedical and Environmental Nanotechnology: From Photocatalytic Detoxification to Targeted TherapeuticsAvraham Dayan, Gideon Fleminger
Toxics|June 25, 2026
Parametric Evaluation of the CFK and the MIL-STD-1472 Equations as Tools for the Estimation of Blood COHb LevelsJacob Alter, Avraham Dayan, Gideon Fleminger
Langmuir : the ACS Journal of Surfaces and Colloids|March 31, 2010
Characterizing the adsorption of peptides to TiO2 in aqueous solutions by liquid chromatographyGolan Gertler, Gideon Fleminger, Hanna Rapaport
RSC Advances|May 11, 2022
RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles - <b>switchable</b> integrin-targeted photodynamic treatment of melanoma cellsAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
Journal of Molecular Recognition : JMR|November 2, 2010
Affinity 2009Hörður Filippusson, George K Ehrlich, Gideon Fleminger
Oncogene|March 16, 2019
Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenaseAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
Journal of Biomedical Materials Research. Part A|November 4, 2018
RGD-modified dihydrolipoamide dehydrogenase as a molecular bridge for enhancing the adhesion of bone forming cells to titanium dioxide implant surfacesAvraham Dayan, Raphael Lamed, Dafna Benayahu, et al.
Origins of Life and Evolution of the Biosphere : the Journal of the International Society for the Study of the Origin of Life|October 18, 2005
The structure and synthetic capabilities of a catalytic peptide formed by substrate-directed mechanism--implications to prebiotic catalysisGideon Fleminger, Tal Yaron, Miriam Eisenstein, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Molecular Recognition : JMR|June 24, 2021
The moonlighting activities of dihydrolipoamide dehydrogenase: Biotechnological and biomedical applicationsGideon Fleminger, Avraham Dayan
Journal of Molecular Recognition : JMR|February 6, 2009
Affinity 2007Gideon Fleminger, George Ehrlich
Molecules (Basel, Switzerland)|April 14, 2026
Titanium Dioxide in Biomedical and Environmental Nanotechnology: From Photocatalytic Detoxification to Targeted TherapeuticsAvraham Dayan, Gideon Fleminger
Toxics|June 25, 2026
Parametric Evaluation of the CFK and the MIL-STD-1472 Equations as Tools for the Estimation of Blood COHb LevelsJacob Alter, Avraham Dayan, Gideon Fleminger
Langmuir : the ACS Journal of Surfaces and Colloids|March 31, 2010
Characterizing the adsorption of peptides to TiO2 in aqueous solutions by liquid chromatographyGolan Gertler, Gideon Fleminger, Hanna Rapaport
RSC Advances|May 11, 2022
RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles - <b>switchable</b> integrin-targeted photodynamic treatment of melanoma cellsAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
Journal of Molecular Recognition : JMR|November 2, 2010
Affinity 2009Hörður Filippusson, George K Ehrlich, Gideon Fleminger
Oncogene|March 16, 2019
Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenaseAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
Journal of Biomedical Materials Research. Part A|November 4, 2018
RGD-modified dihydrolipoamide dehydrogenase as a molecular bridge for enhancing the adhesion of bone forming cells to titanium dioxide implant surfacesAvraham Dayan, Raphael Lamed, Dafna Benayahu, et al.
Origins of Life and Evolution of the Biosphere : the Journal of the International Society for the Study of the Origin of Life|October 18, 2005
The structure and synthetic capabilities of a catalytic peptide formed by substrate-directed mechanism--implications to prebiotic catalysisGideon Fleminger, Tal Yaron, Miriam Eisenstein, et al.
Pageof 2